ニュース

FDA Plans to Limit COVID-19 Vaccines to High-Risk Groups
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for ...
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
STAT4 分
FDA will limit Covid vaccines to people over 65 or at high risk of serious illness, leaders say
The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...
New Trump vaccine policy limits access to COVID shots
It comes as Health Secretary Robert F. Kennedy Jr. and his appointees continue to scrutinize the use of vaccines for a number ...
Trump administration set to limit COVID-19 shot approvals to the elderly, highest-risk
Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...
Healio24 分
FDA will restrict future COVID-19 vaccines based on age, risk factors
FDA officials outlined new restrictions for COVID-19 vaccine approvals in the United States that could limit their use among ...
MedPage Today2 時間
FDA Officials Lay Out New COVID Vaccine Framework
The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...
F.D.A. Poised to Restrict Access to Covid Vaccines
Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...
WebMD2 時間
FDA Approves Novavax COVID Vaccine With Restricted Use
The FDA has approved the Novavax COVID-19 vaccine, called Nuvaxovid, mainly for adults 65 or older, but people ages 12 to 64 with medical conditions that increase their risk of serious illness from ...
After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those ...
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine
(Reuters) -Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 ...
FDA approves Novavax's COVID-19 vaccine with limitations
The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.